Sabah Kadri

  • 1199 Citations
20092019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

PhD, Carnegie Mellon University

… → 2012

Fingerprint Dive into the research topics where Sabah Kadri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Long Noncoding RNA Medicine & Life Sciences
Genes Medicine & Life Sciences
Follicular Adenocarcinoma Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Informatics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 1199 Citations
  • 37 Article
  • 1 Comment/debate
14 Citations (Scopus)

Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

Haas, N. B., Appleman, L. J., Stein, M., Redlinger, M., Wilks, M., Xu, X., Onorati, A., Kalavacharla, A., Kim, T., Zhen, C. J., Kadri, S., Segal, J. P., Gimotty, P. A., Davis, L. E. & Amaravadi, R. K., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2080-2087 8 p.

Research output: Contribution to journalArticle

Hydroxychloroquine
Autophagy
Renal Cell Carcinoma
Disease-Free Survival
Everolimus
2 Citations (Scopus)

Cerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory b-cell malignancies

Coffey, G. P., Feng, J., Betz, A., Pandey, A., Birrell, M., Leeds, J. M., Der, K., Kadri, S., Lu, P., Segal, J., Wang, Y. L., Michelson, G., Curnutte, J. T. & Conley, P. B., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1174-1184 11 p.

Research output: Contribution to journalArticle

B-Cell Antigen Receptors
B-Cell Chronic Lymphocytic Leukemia
Neoplasms
B-Lymphocytes
Interleukin-4

Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing

Ritterhouse, L. L., Parilla, M., Zhen, C. J., Wurst, M. N., Puranik, R., Henderson, C. M., Joudeh, N. Z., Hartley, M. J., Haridas, R., Wanjari, P., Furtado, L. V., Kadri, S. & Segal, J. P., Dec 1 2019, In : Molecular Diagnosis and Therapy. 23, 6, p. 791-802 12 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Mutation
Computer Simulation
nucleophosmin
Recurrence
2 Citations (Scopus)

Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis

Cracolici, V., Kadri, S., Ritterhouse, L. L., Segal, J. P., Wanjari, P. & Cipriani, N. A., Apr 1 2019, In : American Journal of Surgical Pathology. 43, 4, p. 514-522 9 p.

Research output: Contribution to journalArticle

Follicular Adenocarcinoma
Thyroid Nodule
Neoplasm Metastasis
Mutation
Fibrosis
1 Citation (Scopus)

Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis

Corean, J., Furtado, L. V., Kadri, S., Segal, J. P. & Emerson, L. L., May 1 2019, In : International Journal of Surgical Pathology. 27, 3, p. 294-304 11 p.

Research output: Contribution to journalArticle

Adenomatous Polyposis Coli
Molecular Biology
APC Genes
Thyroid Neoplasms
Exons